These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

910 related articles for article (PubMed ID: 27007278)

  • 1. Altered primary chromatin structures and their implications in cancer development.
    Ferraro A
    Cell Oncol (Dordr); 2016 Jun; 39(3):195-210. PubMed ID: 27007278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
    Koschmann C; Nunez FJ; Mendez F; Brosnan-Cashman JA; Meeker AK; Lowenstein PR; Castro MG
    Cancer Res; 2017 Jan; 77(2):227-233. PubMed ID: 28062403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting histone modifications--epigenetics in cancer.
    Waldmann T; Schneider R
    Curr Opin Cell Biol; 2013 Apr; 25(2):184-9. PubMed ID: 23347561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Setting and resetting of epigenetic marks in malignant transformation and development.
    Richly H; Lange M; Simboeck E; Di Croce L
    Bioessays; 2010 Aug; 32(8):669-79. PubMed ID: 20658705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of non-enzymatic glycosylation in the epigenetics of cancer.
    Rehman S; Aatif M; Rafi Z; Khan MY; Shahab U; Ahmad S; Farhan M
    Semin Cancer Biol; 2022 Aug; 83():543-555. PubMed ID: 33276090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics and cancer: altered chromatin remodeling via Snf5 loss leads to aberrant cell cycle regulation.
    Sansam CG; Roberts CW
    Cell Cycle; 2006 Mar; 5(6):621-4. PubMed ID: 16582616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer.
    Tran TQ; Lowman XH; Kong M
    Clin Cancer Res; 2017 Aug; 23(15):4004-4009. PubMed ID: 28404599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chromatin epigenetic modifications in cancer generation].
    Arenas-Huertero F; Recillas-Targa F
    Gac Med Mex; 2002; 138(6):547-55. PubMed ID: 12532619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development.
    Maleszewska M; Kaminska B
    Future Oncol; 2015 Sep; 11(18):2587-601. PubMed ID: 26289459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding the epigenetic language of plant development.
    Ahmad A; Zhang Y; Cao XF
    Mol Plant; 2010 Jul; 3(4):719-28. PubMed ID: 20663898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epigenetics: a novel tool for early diagnosis and tumor therapy].
    Filetici P
    Recenti Prog Med; 2015 Jan; 106(1):32-4. PubMed ID: 25621778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic information in chromatin and cancer.
    Herceg Z
    Eur J Cancer; 2009 Sep; 45 Suppl 1():442-4. PubMed ID: 19775664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of chromatin in tumor cells.
    Drobic B; Dunn KL; Espino PS; Davie JR
    EXS; 2006; (96):25-47. PubMed ID: 16383013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions, aberrations, and advances for chromatin modulation in cancer.
    Conte M; Altucci L
    Cancer Treat Res; 2014; 159():227-39. PubMed ID: 24114483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Step out of the groove: epigenetic gene control systems and engineered transcription factors.
    Verschure PJ; Visser AE; Rots MG
    Adv Genet; 2006; 56():163-204. PubMed ID: 16735158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.